Literature DB >> 25515616

Drug-induced anaemia: a decade review of reporting to the Italian Pharmacovigilance data-base.

Carla Carnovale1, Tatiana Brusadelli, Maria Luisa Casini, Francesca Renda, Sara Ruggieri, Giuseppe Pimpinella, Sonia Radice, Emilio Clementi.   

Abstract

BACKGROUND: Studies investigating drug-induced anaemia are relatively scarce and mostly related to specific drugs or patients with specific pathologies.
OBJECTIVE: To analyse all reports of suspected drug-induced anaemias recorded in the National Pharmacovigilance Database of the Italian Medicines Agency.
METHOD: The cases of suspected drug-induced anaemias analysed were those retrieved from the Italian National Pharmacovigilance Database from January 2001 to December 2013.
RESULTS: The active substances involved were 375 in 3,305 reports of drug-induced anaemia; of these, 72 % were reported as serious. In 35 % of the reports patients were in polytherapy. In 24.3 % of the cases relevant DDIs were identified. We found a PRR value of 57.29 for peginterferon alfa-2a, of 12.57 for ribavirin, of 13 for flu vaccine for the occurrence of autoimmune haemolytic anaemia. The drugs mostly involved in the cases where the Naranjo causality was probable or possible were acetylsalicylic acid, warfarin, ribavirin, peginterferon alfa-2a, carboplatin and acenocoumarol.
CONCLUSIONS: A possible signal was detected for peginterferon alfa-2a, ribavirin and flu vaccine in the occurrence of autoimmune haemolytic anaemia. A great involvement of clopidogrel, enoxaparin, warfarin, ticlopidine and acetylsalicylic acid in preventable DDI-induced anaemia was detected, highlighting a poor awareness among healthcare providers on this issue.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 25515616     DOI: 10.1007/s11096-014-0054-3

Source DB:  PubMed          Journal:  Int J Clin Pharm


  7 in total

1.  Use of proportional reporting ratios (PRRs) for signal generation from spontaneous adverse drug reaction reports.

Authors:  S J Evans; P C Waller; S Davis
Journal:  Pharmacoepidemiol Drug Saf       Date:  2001 Oct-Nov       Impact factor: 2.890

2.  Drug-drug interactions in medical patients: effects of in-hospital treatment and relation to multiple drug use.

Authors:  G I Köhler; S M Bode-Böger; R Busse; M Hoopmann; T Welte; R H Böger
Journal:  Int J Clin Pharmacol Ther       Date:  2000-11       Impact factor: 1.366

3.  Incidence and risk factors of aplastic anemia in Latin American countries: the LATIN case-control study.

Authors:  Eliane Maluf; Nelson Hamerschlak; Alexandre Biasi Cavalcanti; Alvaro Avezum Júnior; José Eluf-Neto; Roberto Passetto Falcão; Irene G Lorand-Metze; Daniel Goldenberg; Cézar Leite Santana; Daniela de Oliveira Werneck Rodrigues; Leny Nascimento da Motta Passos; Luis Gastão Mange Rosenfeld; Marimilia Pitta; Sandra Loggetto; Andreza A Feitosa Ribeiro; Elvira Deolinda Velloso; Andrea Tiemi Kondo; Erika Oliveira de Miranda Coelho; Maria Carolina Tostes Pintão; Hélio Moraes de Souza; José Rafael Borbolla; Ricardo Pasquini
Journal:  Haematologica       Date:  2009-09       Impact factor: 9.941

Review 4.  Drug-induced immune hemolytic anemia.

Authors:  George Garratty
Journal:  Hematology Am Soc Hematol Educ Program       Date:  2009

Review 5.  Is there an association between low dose aspirin and anemia (without overt bleeding)? Narrative review.

Authors:  Helen Gaskell; Sheena Derry; R Andrew Moore
Journal:  BMC Geriatr       Date:  2010-09-29       Impact factor: 3.921

6.  Drug-induced hematologic syndromes.

Authors:  David M Mintzer; Shira N Billet; Lauren Chmielewski
Journal:  Adv Hematol       Date:  2009-07-07

7.  Gender difference in Cisplatin-induced nephrotoxicity in a rat model: greater intensity of damage in male than female.

Authors:  Mehdi Nematbakhsh; Shadi Ebrahimian; Mona Tooyserkani; Fatemeh Eshraghi-Jazi; Ardeshir Talebi; Farzaneh Ashrafi
Journal:  Nephrourol Mon       Date:  2013-06-25
  7 in total
  2 in total

1.  Predictive factors for effectiveness and safety of enoxaparin for total knee arthroplasty in aged Japanese patients: a retrospective review.

Authors:  Akihiro Sonoda; Yuki Kondo; Yasuhiro Tsuneyoshi; Yoshitaka Iwashita; Shoji Nakao; Kazuhisa Ishida; Kentaro Oniki; Junji Saruwatari; Tetsumi Irie; Yoichi Ishitsuka
Journal:  J Pharm Health Care Sci       Date:  2017-01-18

2.  Incidence of Suspected Serious Adverse Drug Reactions in Corona Virus Disease-19 Patients Detected by a Pharmacovigilance Program by Laboratory Signals in a Tertiary Hospital in Spain: Cautionary Data.

Authors:  Elena Ramírez; Mikel Urroz; Amelia Rodríguez; Miguel González-Muñoz; Alberto Martín-Vega; Yuri Villán; Enrique Seco; Jaime Monserrat; Jesús Frías; Antonio J Carcas; Alberto M Borobia
Journal:  Front Pharmacol       Date:  2020-12-03       Impact factor: 5.810

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.